RedHill Biopharma RDHL
NASDAQ RDHL
$0.48 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

RedHill Biopharma (RDHL) Other Operating Expenses (2017)

Updated

RedHill Biopharma (RDHL) recorded Other Operating Expenses of $8.06 million in the year ended Dec 31, 2025, compared with -$2.36 million a year earlier.

Analysis

RedHill Biopharma (RDHL) Other Operating Expenses (2017) Analysis & Trends

Starting with the year ended Dec 31, 2009, RedHill Biopharma's Other Operating Expenses history includes 8 years.

  • Per Business Quant data, RDHL's Other Operating Expenses was -$2.36 million in the year ended Dec 31, 2024 and $44.06 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 RedHill Biopharma 7.09 Mn 7.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 800,000.00
Mar 31, 2017 45,000.00
API Access

RedHill Biopharma Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RDHL&period=max&api_key=YOUR_API_KEY